West Pharmaceutical Services, Inc.
WST
$302.40
-$9.67-3.10%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.00% | 63.29% | 28.03% | 14.23% | -32.83% |
| Total Receivables | 23.11% | 1.82% | 15.16% | 21.57% | 4.69% |
| Inventory | 16.44% | 17.75% | 9.17% | 0.45% | -9.58% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 59.45% | 55.61% | 13.49% | 20.93% | -18.84% |
| Total Current Assets | 25.34% | 28.61% | 17.59% | 13.34% | -13.91% |
|
|
|||||
| Total Current Assets | 25.34% | 28.61% | 17.59% | 13.34% | -13.91% |
| Net Property, Plant & Equipment | 4.49% | 9.46% | 9.51% | 13.85% | 14.35% |
| Long-term Investments | 1.58% | 3.68% | 1.65% | 3.36% | -0.09% |
| Goodwill | 1.58% | 3.68% | 1.65% | 3.36% | -0.09% |
| Total Other Intangibles | -30.00% | -28.70% | -27.64% | -24.81% | -28.06% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 73.21% | 18.70% | -8.67% | 23.02% | 60.50% |
| Total Assets | 13.59% | 17.20% | 11.72% | 13.28% | 0.44% |
|
|
|||||
| Total Accounts Payable | 10.46% | 6.02% | 14.04% | 12.90% | -4.87% |
| Total Accrued Expenses | 75.81% | 55.51% | 40.45% | 12.67% | 1.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 28.72% | 10.10% | -85.59% | -84.87% |
| Total Finance Division Other Current Liabilities | 34.68% | 5.25% | 27.69% | 35.14% | 9.03% |
| Total Other Current Liabilities | 34.68% | 5.25% | 27.69% | 35.14% | 9.03% |
| Total Current Liabilities | 27.97% | 18.99% | 23.02% | -4.59% | -18.77% |
|
|
|||||
| Total Current Liabilities | 27.97% | 18.99% | 23.02% | -4.59% | -18.77% |
| Long-Term Debt | 0.10% | 0.10% | 0.05% | 177.91% | 178.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.36% | 18.24% | -8.40% | -4.14% | -0.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.89% | 10.39% | 16.25% | 11.85% | 4.91% |
| Total Liabilities | 19.71% | 13.83% | 14.23% | 12.17% | 1.45% |
|
|
|||||
| Common Stock & APIC | -8.74% | -54.03% | -55.34% | -64.05% | -72.16% |
| Retained Earnings | 11.03% | 10.57% | 10.51% | 11.24% | 11.23% |
| Treasury Stock & Other | -9.91% | 7.41% | -7.22% | -2.72% | -34.52% |
| Total Common Equity | 11.45% | 18.41% | 10.88% | 13.67% | 0.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.45% | 18.41% | 10.88% | 13.67% | 0.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.45% | 18.41% | 10.88% | 13.67% | 0.09% |
|
|
|||||